Literature DB >> 20045430

Low level exposure to monomethyl arsonous acid-induced the over-production of inflammation-related cytokines and the activation of cell signals associated with tumor progression in a urothelial cell model.

C Escudero-Lourdes1, M K Medeiros, M C Cárdenas-González, S M Wnek, J A Gandolfi.   

Abstract

Human bladder cancer has been associated with chronic exposure to arsenic. Chronic exposure of an immortalized non-tumorigenic urothelial cell line (UROtsa cells) to arsenicals has transformed these cells to a malignant phenotype, but the involved mechanisms are not fully understood. Chronic inflammation has been linked with cancer development mainly because many pro-inflammatory cytokines, growth factors as well as angiogenic chemokines have been found in tumors. In this study the chronology of inflammatory cytokines production was profiled in UROtsa cells chronically exposed to the toxic arsenic metabolite, monomethylarsonous acid [50 nM MMA(III)] to know the role of inflammation in cell transformation. Acute 50 nM MMA(III) exposure induced over-production of many pro-inflammatory cytokines as soon as 12 h after acute exposure. The same cytokines remain over-regulated after chronic exposure to 50 nM MMA(III), especially after 3 mo exposure. At 3 mo exposure the sustained production of cytokines like IL-1, IL-6, IL-8 and TNF is coincident with the appearance of characteristics associated with cell transformation seen in other arsenic-UROtsa studies. The sustained and increased activation of NFkappaB and c-Jun is also present along the transformation process and the phosphorylated proteins p38 MAPK and ERK 1/2 are increased also through the time line. Taken together these results support the notion that chronic inflammation is associated within MMA(III)-induced cell transformation and may act as a promoting factor in UROtsa cell transformation. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20045430      PMCID: PMC2846965          DOI: 10.1016/j.taap.2009.12.029

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  78 in total

1.  Altered regulation of c-jun and its involvement in anchorage-independent growth of human lung cancers.

Authors:  K Maeno; A Masuda; K Yanagisawa; H Konishi; H Osada; T Saito; R Ueda; T Takahashi
Journal:  Oncogene       Date:  2006-01-12       Impact factor: 9.867

2.  Essential roles of PI-3K/Akt/IKKbeta/NFkappaB pathway in cyclin D1 induction by arsenite in JB6 Cl41 cells.

Authors:  Weiming Ouyang; Jingxia Li; Qian Ma; Chuanshu Huang
Journal:  Carcinogenesis       Date:  2005-12-29       Impact factor: 4.944

3.  Influence of interleukin-6 on the invasiveness of human colorectal carcinoma.

Authors:  Chi-Pin Hsu; Yuan-Chiang Chung
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

4.  Monomethylarsonous acid induces transformation of human bladder cells.

Authors:  Tiffany G Bredfeldt; Bhumasamudram Jagadish; Kylee E Eblin; Eugene A Mash; A Jay Gandolfi
Journal:  Toxicol Appl Pharmacol       Date:  2006-06-27       Impact factor: 4.219

Review 5.  Role of oxidative stress in arsenic-induced toxicity.

Authors:  R Clark Lantz; Allison M Hays
Journal:  Drug Metab Rev       Date:  2006       Impact factor: 4.518

Review 6.  The tumor microenvironment: key to early detection.

Authors:  Edgardo V Ariztia; Catherine J Lee; Radhika Gogoi; David A Fishman
Journal:  Crit Rev Clin Lab Sci       Date:  2006       Impact factor: 6.250

7.  Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma.

Authors:  Hirohisa Kai; Yasuhiko Kitadai; Michiyo Kodama; Songde Cho; Tsuyoshi Kuroda; Masanori Ito; Shinji Tanaka; Yasukazu Ohmoto; Kazuaki Chayama
Journal:  Anticancer Res       Date:  2005 Mar-Apr       Impact factor: 2.480

8.  Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer.

Authors:  Catherine Murphy; Maryalice McGurk; Johanna Pettigrew; Alfredo Santinelli; Roberta Mazzucchelli; Patrick G Johnston; Rodolfo Montironi; David J J Waugh
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

9.  Arsenic exposure exacerbates atherosclerotic plaque formation and increases nitrotyrosine and leukotriene biosynthesis.

Authors:  Melisa Bunderson; Diane M Brooks; David L Walker; Michael E Rosenfeld; J Douglas Coffin; Howard D Beall
Journal:  Toxicol Appl Pharmacol       Date:  2004-11-15       Impact factor: 4.219

10.  Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.

Authors:  Fanyin Meng; Yoko Yamagiwa; Yoshiyuki Ueno; Tushar Patel
Journal:  J Hepatol       Date:  2005-12-13       Impact factor: 25.083

View more
  20 in total

Review 1.  BCG response prediction with cytokine gene variants and bladder cancer: where we are?

Authors:  Dinesh Kumar Ahirwar; Parmeet Kaur Manchanda; Rama Devi Mittal; Hemant K Bid
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-20       Impact factor: 4.553

2.  Interleukin-8 (IL-8) over-production and autocrine cell activation are key factors in monomethylarsonous acid [MMA(III)]-induced malignant transformation of urothelial cells.

Authors:  C Escudero-Lourdes; T Wu; J M Camarillo; A J Gandolfi
Journal:  Toxicol Appl Pharmacol       Date:  2011-10-10       Impact factor: 4.219

3.  Arsenic and Chronic Kidney Disease: A Systematic Review.

Authors:  Laura Zheng; Chin-Chi Kuo; Jeffrey Fadrowski; Jackie Agnew; Virginia M Weaver; Ana Navas-Acien
Journal:  Curr Environ Health Rep       Date:  2014-09-01

4.  ATF2 partly mediated the expressions of proliferative factors and inhibited pro-inflammatory factors' secretion in arsenite-treated human uroepithelial cells.

Authors:  Shengnan Liu; Fei Wang; Jieyu Liu; Peiyu Jin; Xiaoyan Wang; Li Yang; Shuhua Xi
Journal:  Toxicol Res (Camb)       Date:  2017-03-29       Impact factor: 3.524

5.  Arsenic alters transcriptional responses to Pseudomonas aeruginosa infection and decreases antimicrobial defense of human airway epithelial cells.

Authors:  Britton C Goodale; Erica J Rayack; Bruce A Stanton
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-15       Impact factor: 4.219

6.  Cortical Astrocytes Acutely Exposed to the Monomethylarsonous Acid (MMAIII) Show Increased Pro-inflammatory Cytokines Gene Expression that is Consistent with APP and BACE-1: Over-expression.

Authors:  C Escudero-Lourdes; E E Uresti-Rivera; C Oliva-González; M A Torres-Ramos; P Aguirre-Bañuelos; A J Gandolfi
Journal:  Neurochem Res       Date:  2016-06-20       Impact factor: 3.996

7.  Stat3 promotes invasion of esophageal squamous cell carcinoma through up-regulation of MMP2.

Authors:  Xaioyan Xuan; Shanshan Li; Xi Lou; Xianzhao Zheng; Yunyun Li; Feng Wang; Yuan Gao; Hongyan Zhang; Hongliu He; Qingru Zeng
Journal:  Mol Biol Rep       Date:  2014-11-19       Impact factor: 2.316

8.  The association of urine arsenic with prevalent and incident chronic kidney disease: evidence from the Strong Heart Study.

Authors:  Laura Y Zheng; Jason G Umans; Fawn Yeh; Kevin A Francesconi; Walter Goessler; Ellen K Silbergeld; Karen Bandeen-Roche; Eliseo Guallar; Barbara V Howard; Virginia M Weaver; Ana Navas-Acien
Journal:  Epidemiology       Date:  2015-07       Impact factor: 4.822

9.  Global gene expression changes in human urothelial cells exposed to low-level monomethylarsonous acid.

Authors:  Matthew Medeiros; Xinghui Zheng; Petr Novak; Shawn M Wnek; Vivian Chyan; Claudia Escudero-Lourdes; A Jay Gandolfi
Journal:  Toxicology       Date:  2011-11-17       Impact factor: 4.221

10.  Transcriptional Modulation of the ERK1/2 MAPK and NF-κB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer.

Authors:  Kathryn A Bailey; Kathleen Wallace; Lisa Smeester; Sheau-Fung Thai; Douglas C Wolf; Stephen W Edwards; Rebecca C Fry
Journal:  J Can Res Updates       Date:  2012-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.